AMN Healthcare Q3 revenue falls 8% to $634.5 million; GAAP profit rises on Smart Square gain
AMN Healthcare reported third quarter 2025 revenue of $634.5 million, down 8% from a year earlier, and GAAP net income of $29.3 million, or $0.76 per diluted share, versus $0.18 a year earlier. GAAP profit included a $39.2 million gain on the sale of Smart Square, and adjusted diluted EPS fell 36% to $0.39, so shareholders face a mixed picture. The company guided fourth quarter revenue to $715 million to $730 million, 1% to 3% below the prior year.
Key points
- Q3 2025 revenue $634.5 million, down 8% year over year; adjusted EBITDA $57.5 million, down 22%
- GAAP diluted EPS $0.76 versus $0.18 a year earlier; adjusted diluted EPS $0.39 versus $0.61
- Q3 income from operations included a $39.2 million gain on the sale of Smart Square
- Q4 2025 guidance: revenue $715 million to $730 million, 1% to 3% lower than the prior year
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 6:57 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 06, 2025.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.